Maa: Uusi-Seelanti
Kieli: englanti
Lähde: Ministry for Primary Industries
equine influenza virus (inactivated)
Ministry for Primary Industries
equine influenza virus (inactivated)
equine influenza virus (inactivated) 0 vaccine
Vaccine
ACVM Registered
2005-12-22
NZ LABEL FOR INSERT FOR ANIMAL USE ONLY KEEP OUT OF REACH OF CHILDREN TRADE NAME Equilis® Prequenza ACTIVE INGREDIENT(S) AND QUANTITIES Equilis® Prequenza is a vaccine suspension containing per 1ml: • Equine Influenza virus strains: • A/equine-2/South Africa/4/03 50 AU* • A/equine-2/Newmarket/2/93 50 AU • Purified saponin (adjuvant) : 375 µg • Cholesterol 125 µ g • Phosphatidylcholine 62.5 µ g. * antigenic units PRESENTATION Cardboard box with 10 x 1 mL glass vials or cardboard box with 10, 5 or 1 x 1 mL pre- filled syringe (needle enclosed). INDICATION Active immunisation of horses from 6 months of age against equine influenza to reduce clinical signs and virus excretion after infection. Onset of immunity: 2 weeks after the primary vaccination course Duration of immunity: 5 months after the primary vaccination course. 12 months after the first revaccination. DIRECTIONS FOR USE By law the distribution and use of this product must comply with the requirements of the relevant operating plan. • Use in healthy horses only. Intramuscular injection of one dose (1 ml) per animal. • Allow the vaccine to reach room temperature (15-25°C) before use. • Shake well before use. ADVERSE EFFECTS, PRECAUTIONS AND CONTRAINDICATIONS • Do not mix the vaccine with other vaccines, or administer another vaccine shortly before or after vaccination with this product. • Accidental self-injection may lead to a severe local allergic reaction. Consult a physician immediately and show this package insert to the physician. • A transient swelling may occur after vaccination regressing within 2 days. In some cases, fever may occur after vaccination. • Avoid intravenous injection. WITHHOLDING PERIODS Meat: Nil. Milk: Nil. STORAGE • Store in the dark between 2 °C and 8 °C. Do not freeze. • Avoid prolonged or repetitive exposure to high ambient temperatures following withdrawal from the refrigerator prior to use. • Protect from direct sunlight. • Keep the vial in the outer carton, in order to protect from l Lue koko asiakirja